Novel Adeno-Associated Virus Serotypes Efficiently Transduce Murine Photoreceptors
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Severe inherited retinal diseases, such as retinitis pigmentosa and Leber congenital amaurosis, are caused by mutations in genes preferentially expressed in photoreceptors. While adeno-associated virus (AAV)-mediated gene transfer can correct retinal pigment epithelium (RPE) defects in animal models, approaches for the correction of photoreceptor-specific diseases are less efficient. We evaluated the ability of novel AAV serotypes (AAV2/7, AAV2/8, AAV2/9, AAV2rh.43, AAV2rh.64R1, and AAV2hu.29R) in combination with constitutive or photoreceptor-specific promoters to improve photoreceptor transduction, a limiting step in photoreceptor rescue. Based on a qualitative analysis, all AAV serotypes tested efficiently transduce the RPE as well as rod and cone photoreceptors after subretinal administration in mice. Interestingly, AAV2/9 efficiently transduces Müller cells. To compare photoreceptor transduction from different AAVs and promoters in both a qualitative and quantitative manner, we designed a strategy based on the use of a bicistronic construct expressing both enhanced green fluorescent protein and luciferase. We found that AAV2/8 and AAV2/7 mediate six- to eightfold higher levels of in vivo photoreceptor transduction than AAV2/5, considered so far the most efficient AAV serotype for photoreceptor targeting. In addition, following subretinal administration of AAV, the rhodopsin promoter allows significantly higher levels of photoreceptor expression than the other ubiquitous or photoreceptor-specific promoters tested. Finally, we show that AAV2/7, AAV2/8, and AAV2/9 outperform AAV2/5 following ex vivo transduction of retinal progenitor cells differentiated into photoreceptors. We conclude that AAV2/7 or AAV2/8 and the rhodopsin promoter provide the highest levels of photoreceptor transduction both in and ex vivo and that this may overcome the limitation to therapeutic success observed so far in models of inherited severe photoreceptor diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RPE cells can be targeted using AAV1, AAV4, or AAV6 vectors or with the engineered AAV2-7m8 vector, and photoreceptors and Müller glial cells are targeted by serotypes AAV2, AAV5, AAV6, AAV7, AAV8, and AAV9 as well as engineered AAV2-7m8 and AAV8BP2 vectors.56,112–116”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [114]
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520 · cited 1×
“To evaluate the tropism of novel AAV serotypes following subretinal delivery to the adult murine retina and to determine if one is selective for photoreceptors, we generated AAV2/7 (25), AAV2/8 (25), AAV2/9 (23), AAV2/rh.”
MethodSelf-citationGene therapy restores vision in a canine model of childhood blindness
Acland, G. M., Aguirre, G. D., Ray, J., Zhang, Q., Aleman, T. S., Cideciyan, A. V., Pearce-Kelling, S. E., Anand, V., Zeng, Y., Maguire, A. M., et al. (2001) · Nature Genetics · doi:10.1038/ng0501-92 · Cited by 1,202
Retinal Stem Cells in the Adult Mammalian Eye
Tropepe, V., Coles, B. L. K., Chiasson, B. J., Horsford, D. J., Elia, A. J., McInnes, R. R., & van der Kooy, D. (2000) · Science · doi:10.1126/science.287.5460.2032 · Cited by 1,081 · cited 1×
“This limitation hampers the possibility of genetically modifying retinal stem cells derived from the adult eye (54), which can be used as tools for cell therapy of retinal degenerations.”
BackgroundClades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues
Gao, G., Vandenberghe, L. H., Alvira, M. R., Lu, Y., Calcedo, R., Zhou, X., & Wilson, J. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6381-6388.2004 · Cited by 1,070 · cited 6×
“64 (23) and was optimized for production by”
BackgroundMethodInfluentialSelf-citationRabinowitz, J. E., Rolling, F., Li, C., Conrath, H., Xiao, W., Xiao, X., & Samulski, R. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.2.791-801.2002 · Cited by 762 · cited 1×
“others have demonstrated that it is possible to tailor somatic transgene expression on distinct retinal cell types in the adult and fetal retina by exchanging the AAV capsids among the various AAV serotypes and that this may impact the therapeutic outcome in animal models of retinal diseases (7, 44, 51, 57).”
BackgroundNew recombinant serotypes of AAV vectors
Gao, G., Vandenberghe, L., & Wilson, J. (2005) · Current Gene Therapy · doi:10.2174/1566523054065057 · Cited by 487
Self-citationHermonat, P. L., & Muzyczka, N. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.20.6466 · Cited by 481 · cited 1×
“Since the generation of the first AAV vector (30, 53) (AAV2/2, in which the first number defines the vector genome and the second the capsid), dozens of AAV variants have been isolated, and some of them have been converted into gene delivery vehicles (11, 12, 23–25, 45).”
BackgroundAcland, G. M., Aguirre, G. D., Bennett, J., Aleman, T. S., Cideciyan, A. V., Bennicelli, J., Dejneka, N. S., Pearce-Kelling, S. E., Maguire, A. M., Palczewski, K., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.08.008 · Cited by 477
Rutledge, E. A., Halbert, C. L., & Russell, D. W. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.309-319.1998 · Cited by 452
Research works printed but not linked: 3
- Dryja, T. 2001. Retinitis pigmentosa and stationary night blindness, p.5903 -5933. In C. R. Scriver, A. L. Beaudet, W. Sly, and D. M. Valle (ed.), The metabolic and molecular bases of inherited disease, 8th ed.,vol. IV. McGraw-Hill, New York, NY.
- Gregory-Evans, K., and R. G. Weleber. 2001. Retinitis pigmentosa and allied disorders in retina, p.362-460. In S. J. Ryan (ed.), Retinavol. 1, 3rd ed. Mosby, St. Louis, MO.
- 10.1128/mcb.4.10.2072-2081.1984 · doi:10.1128/mcb.4.10.2072-2081.1984 · Paper page
Cited by
Items 201–245 of 245
Brillante, S., Volpe, M., Diana, A., Negueruela, S., Molinari, M., Saurino, R., Cipollaro, E., Polishchuk, E., Tenderini, E., Damiano, C., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2504764123 · Cited by 2
“AAV2/8 is currently the most efficient AAV serotype for targeting the RPE and PRs upon subretinal administration in several species, including mice (45).”
Petrogiannakis, G., Guadagnino, I., Negueruela, S., Guida, M. D., Marrocco, E., Pizzo, M., Torella, A., Zanobio, M., Karali, M., Medina, D. L., et al. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102434 · Cited by 3
[Gene therapy for hereditary ophthalmological diseases: Advances and future perspectives].
Chacon-Camacho, O. F., Astorga-Carballo, A., & Zenteno, J. C. (2015) · PubMed · Cited by 7
Gene Therapy for Retinal Disease
Bennett, J., & Maguire, A. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0737-9.00034-5 · Cited by 2
Genersatztherapie bei hereditären Netzhauterkrankungen
Mühlfriedel, R., Sothilingam, V., Tanimoto, N., & Seeliger, M. W. (2017) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/s-0043-101817 · Cited by 3
“[2] Allocca M, Mussolino C, Garcia-Hoyos M et al.”
BackgroundViral vectors for gene delivery
Liang, K. J., & Samulski, R. J. (2015) · doi:10.4155/fseb2013.14.165 · Cited by 2
AAV-mediated transduction of songbird retina
Seth, P. K., Heyers, D., Satish, B., Mendoza, E., Haase, K., Borowsky, L., Musielak, I., Koch, K., Feederle, R., Scharff, C., et al. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1549585 · Cited by 1
Domain-specific functions of LRIT3 in synaptic assembly and retinal signal transmission
Hasan, N., & Gregg, R. G. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113097 · Cited by 1
“To limit expression to either rods or cones, we used the rhodopsin (RHO) promoter (22) or the GNAT2 promoter (23), respectively.”
Cao, B., Almansa-Garcia, A.-C., Sen, M., Mühlfriedel, R., Seeliger, M. W., Petremann-Dumé, A.-S., Kilger, E., Vollert, A., Bolz, S., Henes, C., et al. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114670 · Cited by 2
Recent Developments in Maculopathy
Bandello, F. M., Battista, M., Brambati, M., Starace, V., Arrigo, A., & Parodi, M. B. (2019) · Springer eBooks · doi:10.1007/978-3-030-25389-9_6 · Cited by 1
Michalakis, S., Gerhardt, M.-J., Priglinger, C., & Priglinger, S. G. (2021) · Springer eBooks · doi:10.1007/978-3-319-90495-5_150-1 · Cited by 1
Adeno-associated Viral Vectors in the Retina: Delivering Gene Therapy to the Right Destination
Rudnick, N. D., Kim, L. A., & Comander, J. (2022) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000416 · Cited by 1
Michalakis, S., Gerhardt, M.-J., Priglinger, C., & Priglinger, S. G. (2022) · Springer eBooks · doi:10.1007/978-3-030-42634-7_150 · Cited by 1
Viral‐Mediated Delivery of shRNA and miRNA
Manfredsson, F. P. (2013) · Wiley eBooks · doi:10.1002/9781118610749.ch11 · Cited by 2
Gene therapy for Stargardt and other ABCA4-related diseases: lessons from RPE65-LCA trials
Silva, N. F. A. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Askou, A. L., & Corydon, T. J. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2389-2_3
Effects of neuronal Nogo-A on properties of excitatory synapses of the sensorimotor cortex
Case, A. M. (2011) · Loyola eCommons (Loyola University of Chicago)
Expanding AAV cargo capacity for gene therapy of Stargardt disease
Trapani, I. (2014)
EUROPEAN SCHOOL OF MOLECULAR MEDICINE
Napoli, S. D. (2010)
EXPERIMENTAL AND CLINICAL OCULAR GENE THERAPY
Bemelmans, A., & Sahel, J. (2019) · WORLD SCIENTIFIC (EUROPE) eBooks · doi:10.1142/9781786346889_0025
AAV-Nrf2 Mediated Rescue of Oxidative Stress in Mouse Models
Liang, K. J. (2015) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/tmc2-r921
Hasan, N., Pangeni, G., Cobb, C. A., Ray, T., Nettesheim, E. R., Ertel, K. J., Lipinski, D. M., McCall, M. A., & Gregg, R. G. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3276047
Gene Therapy for Retinal Disease
McClements, M. E., & MacLaren, R. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800563-7.00011-7 · Cited by 1
[Expression pattern of different serotypes of adeno-associated viral vectors in mouse retina].
Hu, S., & Yang, L. (2020) · PubMed Central · doi:10.19723/j.issn.1671-167x.2020.05.008
Rescue of inherited retinal degeneration associated with Aipl1 defects
Ku, C. A. (2012) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.4880
Optogenetic Prosthetization of Retinal Bipolar Cells
Rotov, A. Y., & Firsov, M. L. (2022) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093022060011 · Cited by 1
A DNA base-specific sequence interposed between CRX and NRL contributes to RHODOPSIN expression
Maritato, R., Medugno, A., D’Andretta, E., Riso, G. D., Lupo, M., Botta, S., Marrocco, E., Renda, M., Sofia, M., Mussolino, C., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-76664-8
“To transduce photoreceptors, we used the extensively validated subretinal delivery of AAV serotype 8 72 at a dose of 1 × 10 9 (AAV8 genome copies, GC) in adult C57BL/6 mice (4 weeks old).”
MethodSelf-citationOne down but many more to go: the state of gene therapy for inherited retinal disease
Tan, T., Sun, C., Poh, S. S. J., Lim, J., Teo, J. X. J., Dey, S., Chua, Z., Guo, J., Wang, Z., Tay, H. G., et al. (2025) · Regenerative Medicine · doi:10.1080/17460751.2025.2571360
Modulation of the intraocular immune environment by viral gene transfer in mouse models of uveitis
Chu, C. J. (2015) · UCL Discovery (University College London)
Preclinical CRX augmentation therapies for CRX -associated autosomal dominant cone-rod dystrophiesPreprint
Sun, C., Fitzpatrick, M. J., Kerschensteiner, D., & Chen, S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.23.707517
El-Kalaani, A. M., ten Brink, J. B., Boon, C. J. F., & Koster, C. (2026) · Gene Therapy · doi:10.1038/s41434-026-00601-9
“Choosing a suitable AAV serotype can increase tissue speci fi city [25, 26].”
Lim, H., Choi, S., Jeon, Y.-E., Park, H., Choi, Y., Elangovan, M., Lee, N. K., Kwon, S. J., & Chang, J. W. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153620
Orhan, E. (2015) · theses.fr (ABES) · doi:10.70675/ba724469z6578z49fez8bc9z133cbd455f73
“In addition, different combinations of natural AAV variant capsids of rAAV2 as rAAV2/2 and rAAV2/5 (141), rAAV2/7, rAAV2/8 and rAAV2/9 (142) were described to target photoreceptors and RPE when injected subretinally in mice.”
BackgroundEvolution dirigée de virus adéno-associés pour un transfert de gène efficace dans le système visuel
Planul, A. (2017) · theses.fr (ABES) · doi:10.70675/c9b178a1z8ba4z4451za409z4e80a603376f · Cited by 1
Leite, G. D. F. (2017) · theses.fr (ABES) · doi:10.70675/ea0be1b4zfae0z4e90z811cz71c3a7621eb2
Development of safe and efficient aav vectors for retinal gene therapy
Khabou, H. (2018) · theses.fr (ABES) · doi:10.70675/aa896663z9772z4d87z9bd1z247af1f0e3f1
“We therefore evaluated potential photoreceptor transduction with AAV9 and its 7m8 variant under a rhodopsin promoter (Allocca et al., 2007) (Fig.”
BackgroundChen, X., Xu, X., Cao, S., Chunyan, P., Wei, S., 侯豹可, & Zhou, H. (2026) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2026.06.005
Possible involvement of the mesenchymal cell marker Meflin in regeneration after retinal injury
Okuda, D., Mii, S., Miyai, Y., Kato, K., Ando, R., Shiraki, Y., Esaki, N., Yamada, K., Shimizu, H., Ushida, H., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-58893-1
Ma, P., Sun, X. G., Xu, S., Yang, M., Gao, C., Chen, X., Li, G., Zeng, W., Renger, J. J., & Xue, Y. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.25.740701
“AAV8 was selected because it is publicly described and widely used and transduces ocular cell types efficiently in preclinical models (Allocca et al., 2007; Vandenberghe et al., 2011; Xiong et al., 2019; Xue et al., 2024, 2021).”
Zhang, Y., Luan, F., Feng, J., Sun, W., & Tao, Y. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115289 · Cited by 1
Optogenetic vision restoration: translational barriers and emerging therapeutic strategies
Nakada, N. (2026) · Gene Therapy · doi:10.1038/s41434-026-00640-2
From retina to brain: Viral tools for targeting retinal cells and mapping visual circuits
Talla, V., & Park, K. K. (2026) · Molecules and Cells · doi:10.1016/j.mocell.2026.100403
Metadata
- Authors
- Allocca, M., Mussolino, C., Garcia-Hoyos, M., Sanges, D., Iodice, C., Petrillo, M., Vandenberghe, L. H., Wilson, J. M., Marigo, V., Surace, E. M., & Auricchio, A.
- Affiliations
- European School of Molecular Medicine (IT)
- Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy
- University of Modena and Reggio Emilia (IT)
- Telethon Institute Of Genetics And Medicine (IT)
- University of Pennsylvania (US)
- Federico II University Hospital (IT)
- ORCID
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2007-10-15
- Volume
- 81
- Issue
- 20
- Pages
- 11372-11380
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC2045569
- OpenAlex
- W2155190242
- Cited by
- 246
- References
- 59
- Citations by year
- 2026: 11 · 2025: 9 · 2024: 6 · 2023: 10 · 2022: 11 · 2021: 14 · 2020: 10 · 2019: 14 · 2018: 12 · 2017: 16 · 2016: 7 · 2015: 30 · 2014: 11 · 2013: 16 · 2012: 13
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Funders
- National Eye Institute (R01EY015136)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- adeno-associated virus serotypes, phototransduction, AAV2/8, AAV2/9, rhodopsin promoter, retinitis pigmentosa, Leber congenital amaurosis, inherited retinal disease, subretinal gene therapy, Müller cells, retinal progenitor cells, AAV2/5, luciferase reporter
- MeSH terms
- Dependovirus, Animals, Genetic Vectors, Photoreceptor Cells, Promoter Regions, Genetic, Retina, Rhodopsin, Serotyping, Transduction, Genetic, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.